Invention Grant
- Patent Title: Sustained-release tramadol formulations with 24-hour efficacy
- Patent Title (中): 持续释放曲马多配方，具有24小时功效
-
Application No.: US11112008Application Date: 2005-04-22
-
Publication No.: US07988998B2Publication Date: 2011-08-02
- Inventor: Vincent Lenaerts , Patricia Laure Ouadji-Nijki , Jonathan Bacon , Rachid Ouzérourou , Sonia Gervais , Miloud Rahmouni , Damon Smith
- Applicant: Vincent Lenaerts , Patricia Laure Ouadji-Nijki , Jonathan Bacon , Rachid Ouzérourou , Sonia Gervais , Miloud Rahmouni , Damon Smith
- Applicant Address: CA Quebec IE Dublin BB Hastings, Christ Church
- Assignee: Labopharm Inc.,Labopharm Europe Limited,Labopharm (Barbados) Limited
- Current Assignee: Labopharm Inc.,Labopharm Europe Limited,Labopharm (Barbados) Limited
- Current Assignee Address: CA Quebec IE Dublin BB Hastings, Christ Church
- Agency: Goodwin Procter LLP
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/22 ; A61K9/24 ; A61K9/28 ; A61K9/30 ; A61K9/42
Abstract:
A sustained-release tramadol formulation oral administration is provided which, upon initial administration of one dose, provides an analgesic effect within 2 hours, which analgesic effect continues for at least 24 hours after administration.
Public/Granted literature
- US20090047345A9 Sustained-release tramadol formulations with 24-hour efficacy Public/Granted day:2009-02-19
Information query
